BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Telix Doses First US Patient In Phase Three BiPASS Prostate Cancer Imaging Trial

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...

January 20, 2026 | News

Harbour BioMed Strengthens Strategic Ties With Spruce Biosciences Through Equity Stake

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in imm...

January 20, 2026 | News

AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma

AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietar...

January 20, 2026 | News

D3 Bio Secures FDA IND Clearances To Advance KRAS G12D And G12C Clinical Programme

D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...

January 20, 2026 | News

Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad

As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...

January 19, 2026 | News

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...

January 19, 2026 | News

Antengene Showcases Next Phase Of Global Innovation At J P Morgan Healthcare Conference

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...

January 19, 2026 | News

Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026

Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...

January 15, 2026 | News

Ractigen Doses First Patient In Phase Two Trial Of RAG 17 For SOD1 Mutated Als

The initial dosing occurred at Second Affiliated Hospital, Zhejiang University School of Medicine, under the leadership of Dr. Zhi-Ying Wu, head...

January 15, 2026 | News

ElpasBio And Fosun Kairos Partner To Commercialise AlloJoin Stem Cell Therapy For Knee Osteoarthritis In Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a colla...

January 15, 2026 | News

Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model

Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...

January 15, 2026 | News

Management of Relapsed/Refractory Multiple Myeloma

Doctors and researchers have made huge steps in treating this blood cancer lately. Yet, most people face a time when the cancer returns or stops responding...

January 14, 2026 | News

Suvoda Builds A Unified Clinical Trial Platform Through Greenphire Merger And AI Innovation In 2025

Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patient...

January 14, 2026 | News

WuXi Biologics Secures UK MHRA GMP Clearance For Wuxi Ophthalmic Manufacturing Sites

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...

January 14, 2026 | News

Stay Connected